Next-Generation B-NDG Mice: Improved Immunodeficient Models for Research and Discovery
Speaker: John Charpentier, Ph.D, Business Development Manager, Biocytogen Boston
- Introduced Biocytogen’s highly immunodeficient B-NDG mouse model
- Discussed our latest, next-generation B-NDG-derived models, such as the B-NDG β2m KO, B-NDG HLA-A2.1, and B-NDG hSIRPα/hCD47 models
- Described how B-NDG models recapitulate critical aspects of human biology, making them a powerful tool for biomedical research
